Because they grow rapidly in early stages, triple-negative breast tumors often respond well initially to older chemotherapies that kill dividing cells, but a greater percentage of women diagnosed with this type of breast cancer die within five years of ... [...]
The results published today in the journal Science Translational Medicine showed some success: seven patients saw declines in levels of prostate-specific antigen, or PSA, linked to the cancer during treatment and 10 responded to conventional care after ... [...]
A new study supports a growing body of research suggesting a safe and effective role for natural steroid hormones in treating postmenopausal breast cancer, with fewer detrimental side effects and improved health profile than with standard anti-hormone ... [...]